Nobeoka, Japan

Masateru Kobayashi


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Nobeoka, JP (1982 - 1984)
  • Nobeoaka, JP (1984)

Company Filing History:


Years Active: 1982-1984

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Masateru Kobayashi: Innovator in Pharmaceutical Chemistry

Introduction

Masateru Kobayashi is a notable inventor based in Nobeoka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel thioesters that serve as acylating agents. With a total of 6 patents to his name, Kobayashi's work has had a substantial impact on antibiotic synthesis.

Latest Patents

Kobayashi's latest patents focus on the synthesis of cephalosporin compounds. His innovative approach involves the use of 1H-1,2,3-triazol-5-ylthio esters, which are effective as active esters in the synthesis of these important antibiotics. The novel thioesters can be prepared by reacting a thiol or its derivative with an acetic acid derivative. This process allows for the safe and efficient production of cephalosporin derivatives, which are known for their high antimicrobial activity.

Career Highlights

Throughout his career, Masateru Kobayashi has worked with prominent companies in the chemical industry. Notably, he has been associated with Asahi Kasei Kogyo Kabushiki Kaisha and Asahi Chemical Industry Co., Ltd. His work in these organizations has contributed to advancements in pharmaceutical applications and chemical processes.

Collaborations

Kobayashi has collaborated with several professionals in his field, including Chisei Shibuya and Masahiro Murakami. These collaborations have further enhanced his research and development efforts in pharmaceutical chemistry.

Conclusion

Masateru Kobayashi's contributions to the field of pharmaceutical chemistry, particularly through his innovative patents, have established him as a key figure in antibiotic synthesis. His work continues to influence the development of effective antimicrobial agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…